Drug Search Results
More Filters [+]

Trimetazidine

Alternative Names: trimetazidine, vastarel
Latest Update: 2024-12-12
Latest Update Note: Clinical Trial Update

Product Description

Trimetazidine is an orally available small molecule compound with anti-ischemic, and potential immunomodulating and antineoplastic properties. Although its exact mechanism is not yet fully elucidated, it is postulated that upon administration, trimetazidine selectively inhibits long-chain 3-ketoacyl coenzyme A thiolase (LC 3-KAT), the final enzyme in the free fatty acid (FFA) beta-oxidation pathway.

Mechanisms of Action: CPT1 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Argentina | Austria | Bangladesh | Bosnia | Brazil | Bulgaria | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | France | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Yuanda Pharmaceutical (China)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trimetazidine

Countries in Clinic: China

Active Clinical Trial Count: 3

Highest Development Phases

Phase 1: Angina Pectoris|Angina, Stable|Tinnitus|Vertigo

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20132490

P1

Active, not recruiting

Tinnitus|Angina Pectoris|Vertigo

2015-05-29

CTR20210089

P1

Not yet recruiting

Angina, Stable|Angina Pectoris

None

CTR20202539

P1

Not yet recruiting

Angina, Stable|Angina Pectoris

None

Recent News Events